Health of 227 children born after controlled ovarian stimulation for in vitro fertilization using the luteinizing hormone-releasing hormone antagonist cetrorelix

By Ludwig M.   Riethmuller-Winzen H.   Felberbaum R.E.   Olivennes F.   Albano C.   Devroey P.   Diedrich K.  

Fertility and Sterility, Vol. 75, Iss. 1, 2001-01 ,pp. : 18-22

Elsevier

Access to resources Recommend Favorite

First live birth after ovarian stimulation using a chimeric long-acting human recombinant follicle-stimulating hormone (FSH) agonist (recFSH-CTP) for in vitro fertilization

By Beckers N.G.M.   Macklon N.S.   Devroey P.   Platteau P.   Boerrigter P.J.   Fauser B.C.J.M.  

Fertility and Sterility, Vol. 79, Iss. 3, 2003-03 ,pp. : 621-623

Elsevier

Access to resources Recommend Favorite

Differences in serum LH and FSH levels using depot or daily GnRH agonists in controlled ovarian stimulation: influence on ovarian response and outcome of ART

By Sonntag Barbara   Kiesel Ludwig   Nieschlag Eberhard   Behre Hermann  

Journal of Assisted Reproduction and Genetics, Vol. 22, Iss. 7-8, 2005-08 ,pp. : 277-283

Springer Publishing Company

Access to resources Recommend Favorite

Short Communication: FSH Time-Concentration Profiles Before and After Administration of 0.25 mg Cetrorelix in the GnRH-Antagonist Multiple-Dose Protocol for Ovarian Hyperstimulation

By Griesinger G.   Finas D.   Alisch A.   Roiha K.   Schultze-Mosgau A.   Schröder A. K.   Dafopoulos K.   Diedrich K.   Felberbaum R.  

Journal of Assisted Reproduction and Genetics, Vol. 21, Iss. 7, 2004-07 ,pp. : 279-282

Springer Publishing Company

Access to resources Recommend Favorite

Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonists (Cetrorelix) in women with tubal infertility

By Felberbaum R.E.   Reissmann T.   Kupker W.   Bauer O.   Al Hasani S.   Diedrich C.   Diedrich K.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 61, Iss. 2, 1995-08 ,pp. : 151-155

Elsevier

Access to resources Recommend Favorite